Clinical
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
FDA approves 5-year use for etonogestrel implant 68 mg contraceptive
2
Barbara Levy, MD: Patient-collected hrHPV testing is "huge" part of updated cervical cancer guideline
3
Prenatal acid-suppressive medications not linked to neuropsychiatric disorders in offspring
4
RE104 30 mg demonstrates efficacy and safety in new phase 2 data for postpartum depression
5